Table 5 Heterogeneity results by Cochran’s Q test of PWY0.1298..superpathway.of. pyrimidine.deoxyribonucleosides.degradation on CD25hi %CD4 + and HVEM on CM CD4 + /naive CD4 + /EM CD4 + /CD45RA-CD4 + /CM CD8br.

From: Causal role of the pyrimidine deoxyribonucleoside degradation superpathway mediation in Guillain-Barré Syndrome via the HVEM on CD4 + and CD8 + T cells

Exposures

Outcomes

Cochran’s Q test

Heterogeneity p-value

PWY0.1298..superpathway

of.pyrimidine

deoxyribonucleosides

degradation

CD25hi %CD4 + 

IVW

0.326392016

MR Egger

0.260160373

HVEM on CM CD4 + 

IVW

0.196111793

MR Egger

0.179136069

HVEM on naive CD4 + 

IVW

0.447434837

MR Egger

0.41178957

HVEM on EM CD4 + 

IVW

0.076707454

MR Egger

0.053494634

HVEM on CD45RA- CD4 + 

IVW

0.14300511

MR Egger

0.119619384

HVEM on CM CD8br

IVW

0.423870075

MR Egger

0.363781527

  1. HVEM: herpesvirus entry mediator.